This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fojo, A. Articles by Pastan, I. Search for Related Content PubMed PubMed Citation Articles by Fojo, A. Articles by Pastan, I.

Reduced Drug Accumulation in Multiply Drug-resistant Human KB Carcinoma Cell Lines

Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20205

Human KB cells with increasing resistance to colchicine and other chemotherapeutic agents have been isolated in four sequential steps. This report describes the characterization of drug uptake in the parent and four mutant cell lines. Drug uptake in these cell lines occurred via a nonsaturable process. In general, drug accumulation decreased with increasing drug resistance; this relationship was seen best with colchicine, vincristine, vinblastine, and daunomycin and, to a lesser extent, with actinomycin D. The accumulation of dexamethasone, an agent to which all lines were equally sensitive, was similar for the parent and the four mutants. Drug efflux occurred rapidly, and differences among the various cell lines could be detected within the first minute. In the more resistant lines, a greater percentage of the drug was released more rapidly, although the absolute amount of drug released was less. Verapamil partially reversed the multiple drug-resistance phenotype by increasing the initial rate of uptake and accumulation of drugs in the resistant cell lines without an apparent effect on drug efflux. The results suggest that, in this human epithelial cell, the development of resistance to multiple drugs is complex, with changes in drug uptake, accumulation, and efflux.

Received 7/25/84. Revised 1/ 2/85. Revised 3/11/85. Accepted 3/12/85.

This article has been cited by other articles:

				V. Ali and T. Nozaki Current Therapeutics, Their Problems, and Sulfur-Containing-Amino-Acid Metabolism as a Novel Target against Infections by "Amitochondriate" Protozoan Parasites Clin. Microbiol. Rev., January 1, 2007; 20(1): 164 - 187. [Abstract] [Full Text] [PDF]

				M. Agrawal, J. Abraham, F. M. Balis, M. Edgerly, W. D. Stein, S. Bates, T. Fojo, and C. C. Chen Increased 99mTc-Sestamibi Accumulation in Normal Liver and Drug-resistant Tumors after the Administration of the Glycoprotein Inhibitor, XR9576 Clin. Cancer Res., February 1, 2003; 9(2): 650 - 656. [Abstract] [Full Text] [PDF]

				Q. Mi, B. Cui, G. L. Silva, D. Lantvit, E. Lim, H. Chai, M. You, M. G. Hollingshead, J. G. Mayo, A. D. Kinghorn, et al. Pervilleine A, a Novel Tropane Alkaloid that Reverses the Multidrug-resistance Phenotype Cancer Res., May 1, 2001; 61(10): 4030 - 4037. [Abstract] [Full Text]

				M. Yamazaki, W. E. Neway, T. Ohe, I-W. Chen, J. F. Rowe, J. H. Hochman, M. Chiba, and J. H. Lin In Vitro Substrate Identification Studies for P-glycoprotein-Mediated Transport: Species Difference and Predictability of in Vivo Results J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 723 - 735. [Abstract] [Full Text]

				E. Bello-Reuss, S. Ernest, O. B. Holland, and M. R. Hellmich Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells Am J Physiol Cell Physiol, June 1, 2000; 278(6): C1256 - C1265. [Abstract] [Full Text] [PDF]

				T Litman, M Brangi, E Hudson, P Fetsch, A Abati, D. Ross, K Miyake, J. Resau, and S. Bates The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2) J. Cell Sci., January 6, 2000; 113(11): 2011 - 2021. [Abstract] [PDF]

				M. Arboix, O. G. Paz, T. Colombo, and M. D'Incalci J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1226 - 1230. [Abstract] [Full Text]

				S. Scala, N. Akhmed, U. S. Rao, K. Paull, L.-B. Lan, B. Dickstein, J.-S. Lee, G. H. Elgemeie, W. D. Stein, and S. E. Bates P-Glycoprotein Substrates and Antagonists Cluster into Two Distinct Groups Mol. Pharmacol., June 1, 1997; 51(6): 1024 - 1033. [Abstract] [Full Text]

				S. Thorgeirsson, B. Huber, S Sorrell, A Fojo, I Pastan, and M. Gottesman Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver Science, May 29, 1987; 236(4805): 1120 - 1122. [Abstract] [PDF]

				S. Martin, A. Oduola, and W. Milhous Reversal of chloroquine resistance in Plasmodium falciparum by verapamil Science, February 20, 1987; 235(4791): 899 - 901. [Abstract] [PDF]

				D. Shen, A Fojo, J. Chin, I. Roninson, N Richert, I Pastan, and M. Gottesman Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification Science, May 2, 1986; 232(4750): 643 - 645. [Abstract] [PDF]

				X.-Q. Ren, T. Furukawa, S. Aoki, T. Nakajima, T. Sumizawa, M. Haraguchi, Z.-S. Chen, M. Kobayashi, and S.-i. Akiyama Glutathione-dependent Binding of a Photoaffinity Analog of Agosterol A to the C-terminal Half of Human Multidrug Resistance Protein J. Biol. Chem., June 15, 2001; 276(25): 23197 - 23206. [Abstract] [Full Text] [PDF]